accompanying loss of a normal ciliary structure, while nuclear galectin-3 increased (p < 0.05) in ectopic pregnancies. Epithelial immunostaining for galectin-1 tended to be elevated in fallopian tubes from women with ectopic pregnancy. Coculture of human trophoblast origin SW71 cells significantly increased LGALS1 expression in human fallopian tube epithelial OE-E6/E7 cells, suggesting that trophoblast-derived products regulate LGALS1 expression in the oviductal epithelium. These findings imply a differential contribution of galectin-1 and galectin-3 in the homeostasis of human fallopian tubes and in the pathophysiology of ectopic pregnancy.
Introduction
Successful embryonic implantation at the correct site is crucial for human reproduction. An ectopic pregnancy is defined as a pregnancy where a blastocyst implants outside the normal uterine cavity, and over 95% of ectopic pregnancies are located in the fallopian tube [Walker, 2007; Varma and Gupta, 2012] . Tubal ectopic pregnancy is a life-threatening condition and it is one of the leading causes of maternal death in the first trimester in both developed and developing countries [Farquhar, 2005; Varma and Gupta, 2012] . The etiology of ectopic pregnancy is still unknown, and early diagnosis and treatment prior to rupture of the fallopian tube are essential to reduce the associated morbidity and mortality. The major risk factors for tubal ectopic pregnancy include tubal damage as a result of surgery or infection, cigarette smoking, and in vitro fertilization. These lead to impaired tubal transport that delays the passage of the embryo along the fallopian tube and/or to alterations in the tubal environment that result in early implantation [Shaw et al., 2010b] .
Galectin is a β -galactoside-binding animal lectin that has a high affinity for the N -acetyllactosamine residue (Gal β 1-3/4GlcNAc) of glycoconjugates [Barondes et al., 1994; Hirabayashi et al., 2002] . In mammals, 16 members of galectin have been identified so far, and 11 galectin subtypes exist in human tissues (subtypes 1-4, 7-10, 12, 13, and 16). Galectins are differentially distributed throughout the mammalian body, and they are involved in various biological functions including cell differentiation, migration, and apoptosis, or in pathological events such as inflammation and cancer metastasis [Yang et al., 2008] . Galectin-1 and galectin-3 are the major subtypes expressed in the female reproductive tract. They are abundantly expressed in the uterus and at the utero-placental interface and have been implicated in the process of implantation [Powell, 1980; Hirabayashi and Kasai, 1984; Poirier et al., 1992; von Wolff et al., 2005] . As there is convincing evidence that galectin-1 and galectin-3 contribute to the establishment of successful pregnancy [Blois et al., 2007; Than et al., 2008; Blidner and Rabinovich, 2013; Barrientos et al., 2014] , we hypothesized that galectins expressed in the fallopian tube may have a role in the pathophysiology of ectopic pregnancy.
Although the expression and localization of galectins in the uterus and developing placenta have been examined in various animals [Phillips et al., 1996; Choe et al., 1997; Yang et al., 2012b; Orazizadeh et al., 2013] , only 3 studies have dealt with the expression of galectin-3 in the oviduct/fallopian tube. Galectin-3 has been localized to the epithelium in the fallopian tubes of women [John et al., 2002; Roldán and Marini, 2014] and in the oviducts of cows and pigs [Roldán and Marini, 2014] . However, there is no information about the detailed expression and localization of galectins, particularly galectin-1, in human fallopian tubes across the menstrual cycle and after tubal implantation in ectopic pregnancy. In this study, we investigated the expression and cellular localization of galectin-1 and galectin-3 in fallopian tubes of nonpregnant women throughout the menstrual cycle and in fallopian tubes from women with ectopic pregnancy.
Materials and Methods

Human Fallopian Tubes and Serum Collection
Ethical approval for this study was obtained from the Lothian Research Ethics Committee, and informed written consent was obtained from all of the women participating in this study (LREC 10/S1102/40). Serum samples (10 ml) and biopsies (2-3 cm) in the ampullary region of the fallopian tube were collected from the study participants at the time of hysterectomy for benign gynecological conditions or during surgical management of tubal ectopic pregnancy. The women were between 18 and 45 years of age. The stage of the menstrual cycle of each patient at the time of hysterectomy was determined by histologic examination and staging of an endometrial biopsy taken with the fallopian tube, and measurement of serum estradiol and progesterone levels was done as described previously [Duncan et al., 2011] . Biopsies of nonpregnant fallopian tubes (n = 32) and those from women with tubal ectopic pregnancy (n = 25) free from trophoblast contamination [Duncan et al., 2011] were divided into equivalent portions and either immersed in RNAlater (Ambion, Tex., USA) at 4 ° C overnight, and then flash frozen and stored at − 80 ° C for subsequent RNA extraction, or fixed in 10% neutral-buffered formalin overnight at 4 ° C followed by storage in 70% ethanol and subsequent embedding in paraffin wax for immunohistochemical staining. Information about the samples used in this study is summarized in table 1 , as RNA or paraffin-embedded tissue was not available in some patients. Serum concentrations of female sex steroids and human chorionic gonadotrophin were available in only 7 and 15 samples, respectively, out of the 28 samples of fallopian tubes from women with ectopic pregnancy.
Cell Culture
Human fallopian tube epithelial cells (OE-E6/E7) [Lee et al., 2001] and human first-trimester trophoblast cells (SW71) [Straszewski-Chavez et al., 2009] were maintained in either DMEM or RPMI 1640 medium containing 10% fetal bovine serum, 2 m M L -glutamine, 10 units/ml penicillin, and 0.1 mg/ml streptomycin in 5% CO 2 at 37 ° C. OE-E6/E7 cells in DMEM medium were seeded at 1 × 10 5 cells per well in 12-well dishes. A Transwell ® (Corning, Corning, N.Y., USA) was placed onto each well, and 1 × 10 5 SW71 cells in RPMI 1640 medium were seeded into the insert. 426 insert. They were cultured in 5% CO 2 at 37 ° C for 3 days, and OE-E6/E7 cells were collected for RNA extraction.
Quantitative Reverse Transcription Polymerase Chain Reaction
The fallopian tube tissues used for quantitative gene expression analysis were classified as proliferative phase (n = 8), mid-secretory phase (n = 15), late-secretory to menstrual phase (n = 8), or ectopic pregnancy (n = 25). Total RNA was extracted from frozen human fallopian tube or cultured OE-E6/E7 cells using an RNeasy Mini Kit (Qiagen Ltd., Crawley, UK) according to the manufacturer's protocol. RNA (200 ng) was used to prepare cDNA via TaqMan Reverse Transcription reagents (Applied Biosystems, Foster City, Calif., USA).
The sequences of the primer sets used for this study have been described previously [Nio-Kobayashi et al., 2014] . Primers were prevalidated by standard PCR and by generating standard curves using quantitative reverse transcription polymerase chain reaction (qRT-PCR). Each reaction buffer contained 5.0 μl 2× Power-SYBR ® Green PCR Master Mix (Applied Biosystems), 0.5 μl primer pair (5 μ M ), 3.5 μl nuclease-free H 2 O, and 1.0 μl cDNA, and each reaction was conducted in duplicate. The qRT-PCR cycling program consisted of a denaturing step (95 ° C for 10 min), an annealing and extension step (95 ° C for 15 s and 60 ° C for 1 min repeated for 40 cycles), and a dissociation step (95, 60, and 95 ° C for 15 s each) using a 7900 Sequence Detection System (Applied Biosystems). The relative expression levels of each target to the housekeeping gene (glucose-6-phosphate dehydrogenase: G6PDH), previously validated using geNorm analysis (Primerdesign Ltd., Southampton, UK), were quantified using the Δ Ct or ΔΔ Ct method. After testing for normality, all statistical analyses were performed using unpaired t tests or one-way ANOVA, with pairwise comparison, using GraphPad Prism 6 software (GraphPad Software Inc., San Diego, Calif., USA), and p < 0.05 was considered statistically significant.
Immunohistochemistry
The fixed human fallopian tube tissues collected during the proliferative phase (n = 5), the mid-secretory phase (n = 9), and the late-secretory to menstrual phase (n = 4) and those from women with ectopic pregnancy (n = 26) were available for immunohistochemical analysis. The sections, at a 5-μm thickness, were dewaxed and washed in phosphate-buffered saline (PBS). Subsequently, the sections were incubated with 3% hydrogen peroxide for 20 min and Avidin/Biotin blocking solution (Vector Laboratories Inc., Burlingame, Calif., USA) for 15 min for each reagent. Then the sections were incubated with normal rabbit or goat serum for 60 min at room temperature. They were incubated with goat anti-human galectin-1 antibody (1: 1,000, AF1152; R&D Systems Inc., Minneapolis, Minn., USA) or rabbit anti-human galectin-3 antibody (1: 200, sc-20157; Santa Cruz Biotechnology Inc., Dallas, Tex., USA) in rabbit or goat serum at 4 ° C overnight. Control sections were incubated with nonimmune serum. After washing twice in PBS, the sections were incubated with biotinylated anti-goat or anti-rabbit IgG (1: 500; Vector Laboratories) for 60 min at room temperature. The reaction sites were visualized using a Vectastain ABC Elite Kit (Vector Laboratories) for 60 min followed by an ImmPACT TM DAB Peroxidase Substrate Kit (Vector Laboratories) for 5 min. The sections were counterstained with hematoxylin and observed under a light microscope (BX51; Olympus Corporation, Tokyo, Japan).
To quantify the number of cells with a positive galectin-3 immunoreaction in either the cilia, the nucleus, or the cytoplasm of the fallopian tube epithelium collected in the mid-secretory phase or during surgery for ectopic pregnancy, at least 5 images were taken from the different parts of the representative sections (n = 8 for the mid-secretory phase and n = 10 for ectopic pregnancy) using stratified random sampling, and the ratio of positive cells to total epithelial cells was calculated by observers blinded to the sample source.
Dual Immunohistochemistry
Some sections, after the reaction with anti-galectin-3 antibody overnight, were washed with PBS and subsequently incubated with AlexaFluor 594-labeled anti-rabbit IgG (1: 200; Life Technologies Japan, Tokyo, Japan) for 2 h at room temperature. The sections were blocked with 10% normal goat serum for 60 min at room temperature and then incubated with mouse anti-α-tubulin antibody (1: 2,000; T6793) at 4 ° C overnight. Sections were washed with PBS and incubated with AlexaFluor 488-labeled anti-mouse IgG (1: 200; Life Technologies Japan) for 2 h at room temperature and observed under a confocal laser scanning microscope (FV300; Olympus). Values are means ± SEM unless otherwise stated. hCG = Human chorionic gonadotrophin; IHC = immunohistochemistry. a Significantly higher than the proliferative or late-secretory to menstrual phases (p < 0.01). b Significantly higher than the proliferative phase (p < 0.01). c Significantly lower than the mid-secretory phase (p < 0.0001).
Results
Expression and Localization of Galectin-1 and Galectin-3 in the Fallopian Tubes of Nonpregnant Women across the Menstrual Cycle
We examined the mRNA expression of galectin-1 (LGALS1) and galectin-3 (LGALS3) by qRT-PCR in the fallopian tubes of nonpregnant women during the proliferative, mid-secretory, and late-secretory to menstrual phases. The expression of both LGALS1 and LGALS3 transcripts did not significantly change between these phases ( table 1 ).
To identify cells expressing galectin-1 and galectin-3 in the fallopian tubes of nonpregnant women, we carried out immunohistochemistry using specific antibodies against human galectin-1 and galectin-3. There were no clear differences in the staining pattern of galectins between the phases. Galectin-1 was predominantly localized to stromal cells, largely fibroblasts and extracellular matrix of the lamina propria, while the epithelium showed limited immunoreactivity to galectin-1 ( fig. 1 a, b) . At a higher magnification, epithelial cells were slightly immunoreactive to galectin-1. However, numerous round cells within the epithelium were significantly immunostained for galectin-1 (arrowheads in fig. 1 b, c) . Immunohistochemical images of galectins in the ampullary region of human fallopian tubes from nonpregnant women. Immunoreactivity to galectin-1 is mainly found in the stroma, and the epithelium shows a limited immunoreactivity to galectin-1 ( a , b ). Round cells within the epithelium are positive for galectin-1 immunoreaction (arrowheads in b , c ). Galectin-3 is mainly localized in the apical region of the epithelium, and the stroma is weakly immunoreactive to galectin-3 ( d ). At a higher magnification, galectin-3 immunoreactivity is found in the cilia of ciliated cells ( e , f ) and the apical cytoplasm of secretory cells (arrows in e ). Occasionally, the nuclear and cytoplasmic staining for galectin-3 is observed in both types of epithelial cells (the asterisk in f shows an example in a ciliated cell). Dual immunostaining for galectin-3 (red) and α-tubulin (green) as a marker for cilia clearly demonstrates the positive immunoreaction to galectin-3 in the α-tubulinpositive cilia of ciliated cells ( g-i ) and the apical cytoplasm of α-tubulin-negative nonciliated secretory cells (arrows in g-i ). The localization of immunoreactivities did not change between menstrual phases, and representative tissue sections in the mid-secretory phase are used for illustration. The inset in a is a control section where the primary antibody was omitted. α-tub = α-Tubulin; G1 = galectin-1; G3 = galectin-3.
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In contrast, intense immunoreactivity to galectin-3 was found in the apical region of the epithelium while the stroma was weakly immunoreactive to galectin-3 ( fig. 1 d) . Galectin-3 in the epithelium was mainly localized to the cilia of ciliated cells ( fig. 1 e, f) and the apical cytoplasm of secretory cells (arrows in fig. 1 e) . Occasionally, galectin-3 immunoreactivity was found in the nucleus or whole cytoplasm of both types of epithelial cells in the human fallopian tube (asterisk in fig. 1 f) . Dual immunostaining for galectin-3 and α-tubulin, a marker for cilia, confirmed the localization of galectin-3 both in the α-tubulin-positive cilia of ciliated cells ( fig. 1 g-i) and in the apical cytoplasm of α-tubulin-negative nonciliated secretory cells (arrows in fig. 1 g-i) .
Changes in mRNA Expression and Localization of Galectins in Fallopian Tubes from Women with Ectopic Pregnancy
Among the fallopian tubes collected after ectopic implantation, the mRNA expression of LGALS3 was significantly decreased in fallopian tubes from women with ectopic pregnancy when compared to the fallopian tubes of nonpregnant women during the mid-secretory phase (p < 0.0001; table 1 ). In contrast, LGALS1 expression did not change between two groups ( table 1 ) .
Immunohistochemical analysis of the fallopian tubes from women with ectopic implantation revealed that galectin-1 immunoreactivity was abundant in the stroma, as was seen in the fallopian tubes from nonpregnant women ( fig. 2 a) . However, the epithelium consistently showed elevated immunoreactivity to galectin-1 ( fig. 2 b) with intensified immunolabeling of the round cells within the epithelium (arrowheads in fig. 2 b) . Similar to the findings in nonpregnant women, galectin-3 immunoreactivity was mainly localized to the epithelium ( fig. 2 c) . At a higher magnification, epithelial galectin-3 immunoreaction was found in the cilia of ciliated cells ( fig. 2 d) and the apical region of nonciliated secretory cells (arrows in fig. 2 d) , like the fallopian tubes from nonpregnant women. Nuclear immunostaining for galectin-3 was more frequently observed in the fallopian tubes from women with ectopic pregnancy (asterisks in fig. 2 d) . The immunoreactivity to galectin-3 in α-tubulin-negative secretory cells tended to gather at the plasma membrane rather than the apical cytoplasm (arrows in fig. 2 d, e) .
Cytoplasmic staining for galectin-3 was abundant in both types of cells in the fallopian tube epithelium with ectopic pregnancy, and ciliated cells containing abundant galectin-3 in the cytoplasm appeared to display a scattered or irregular ciliary structure (arrows in fig. 2 f, g ). Dual immunostaining for galectin-3 and α-tubulin clearly demonstrated that cells with abundant immunoreactivity to galectin-3 in the cytoplasm had almost lost the α-tubulin-positive ciliary structure (arrowheads in fig. 2 h-j), while cells devoid of cytoplasmic galectin-3 displayed an intact α-tubulin-positive ciliary structure (arrows in fig. 2 h-j) . The percentage of cells with galectin-3-positive intact cilia tended to decrease in the fallopian tubes from women with ectopic pregnancy ( fig. 2 k, p = 0.0685). On the other hand, the number of epithelial cells with nuclear galectin-3 immunostaining was increased in the fallopian tubes from women with ectopic pregnancy ( fig. 2 l, p < 0.01). The number of epithelial cells with cytoplasmic galectin-3 immunoreactivity in the fallopian tube did not differ between nonpregnancy and ectopic pregnancy ( fig. 2 m) .
These findings suggest that LGALS3 mRNA expression was significantly decreased and alterations in the Galectin-1 immunoreactivity is abundant in the stroma of the fallopian tubes from women with ectopic pregnancy ( a ), as it is in the fallopian tubes from nonpregnant women. At a higher magnification, the immunoreactivity to galectin-1 slightly increased along the entire length of the epithelium ( b ). Intraepithelial round cells are also positive for galectin-1 immunoreaction (arrowheads in b ). Galectin-3 is localized in both the epithelium and the stroma ( c ). At a higher magnification, galectin-3 immunoreactivity is found in the cilia of ciliated cells as it is in the nonpregnant women ( d ), but the nuclear galectin-3 staining in both types of epithelial cells is more frequently observed in the fallopian tubes from women with ectopic implantation (asterisks in d ). Galectin-3 immunoreactivity tends to gather at the apical plasma membrane of α-tubulinnegative nonciliated secretory cells (arrows in d and e ). Cells with abundant cytoplasmic galectin-3 lose their normal ciliary structure (arrows in f and g ). Dual immunostaining for galectin-3 and α-tubulin clearly shows the decreased α-tubulin-immunoreactive ciliary structures in cells with abundant cytoplasmic galectin-3 (arrows in h-j ), whereas an intact α-tubulin-positive ciliary structure is found in cells without cytoplasmic galectin-3 (arrowheads in h-j ). The percentage of epithelial cells with galectin-3-immunoreactive intact cilia tends to decrease in the fallopian tube with ectopic pregnancy ( k ). On the other hand, the number of cells with nuclear staining for galectin-3 is significantly increased in EP ( l ). The number of cells with cytoplasmic staining for galectin-3 does not change between the two groups ( m ). α-tub = α-Tubulin; G1 = galectin-1; G3 = galectin-3; n.s. = not significant. * * p < 0.01. 
Galectin-1 and Galectin-3 Are Inversely Expressed in the Fallopian Tube
To evaluate the influence of serum sex steroids on the expression of galectin mRNA in the fallopian tube, we performed a correlation analysis. Although there was no statistical significance, the expression of LGALS1 and LGALS3 seemed to be differentially correlated to the concentration of serum sex steroids; LGALS1 expression seemed to be positively correlated, whereas LGALS3 appeared to be negatively correlated, to the concentration of both estradiol and progesterone ( fig. 3 a-d) . Interestingly, the mRNA expressions of LGALS1 and LGALS3 were inversely correlated to each other (r = − 0.5134, p < 0.0001; fig. 3 e) . LGALS1 expression in the fallopian tube seems to be positively correlated to the serum concentration of estradiol (n = 35) and progesterone (n = 42) ( a , b ). On the other hand, the expression of LGALS3 seems to be negatively correlated to these female steroids ( c , d ). The expression of LGALS1 and LGALS3 in the fallopian tube is negatively correlated (n = 56) ( e ). n.s. = Not significant.
Changes in Galectin mRNA Expression in Human Fallopian Tube Epithelial OE-E6/E7 Cells Induced by Coculture with Trophoblast-Origin SW71 Cells
To examine whether the presence of the implanting embryo affects the mRNA expression of galectins in human fallopian tube epithelium, we used two types of cells derived from human fallopian tube epithelium (OE-E6/ E7) and human trophoblasts (SW71). OE-E6/E7 cells were cocultured with SW71 cells using the Transwell system for 3 days, and the mRNA expressions of LGALS1 and LGALS3 in OE-E6/E7 cells were analyzed by qRT-PCR.
LGALS1 expression was increased in OE-E6/E7 cells when cocultured with SW71 cells ( fig. 4 a; p < 0.0001) while the mRNA abundance of LGALS3 did not change ( fig. 4 b) . This finding suggests that certain molecules secreted from SW71 cells may stimulate the mRNA expression of LGALS1 in epithelial OE-E6/E7 cells.
Discussion
In this study, we demonstrated the subtype-specific expression and localization of galectin-1 and galectin-3 in the fallopian tubes of women. Galectin-1 was mainly localized to the stroma, but galectin-3 was expressed in apical sites of the epithelium in the fallopian tubes of nonpregnant women. Although the expression of both galectins did not change during the menstrual cycle, the expressions of LGALS1 and LGALS3 were inversely correlated to each other. In the ectopic pregnancies, the expression of LGALS3 was dramatically decreased and the subcellular localization of galectin-3 changed in association with ciliary loss in the fallopian tube epithelium. On the other hand, epithelial immunostaining of galectin-1 slightly increased in the ectopic pregnancies and coculture with trophoblast origin SW71 cells significantly enhanced the expression of LGALS1 in the fallopian tube epithelium-derived OE-E6/E7 cells. Although the detailed function of galectins is still unclear, these results suggest that galectin-1 and galectin-3 may differentially contributed to the pathophysiology of tubal ectopic pregnancy.
We have, for the first time, described here the expression and localization of galectin-1 in human fallopian tubes. Galectin-1 was predominantly localized to cells in the stroma, while minimal immunoreactivity was detected in the epithelium. Interestingly, intraepithelial round cells were immunostained for galectin-1. We believe that these cells are leukocytes as we and other research groups have previously identified leukocytes with a similar morphology in human fallopian tube epithelium by immunohistochemistry [Ulziibat et al., 2006; Shaw et al., 2011] . According to previous studies, most intraepithelial leukocytes are identified as CD8-positive suppressor T lymphocytes [Ulziibat et al., 2006; Shaw et al., 2011] . This suggests a possible contribution of galectin-1 to mucosal immunity in human fallopian tubes. Galectin-1 is well known to regulate inflammation [Liu, 2000; Cedeno-Laurent and Dimitroff, 2012] and to be a pivotal regulator of fetomaternal immune tolerance during pregnancy [Blois et al., 2007] .
Previous studies have reported that galectin-3 is localized to the apical surface of nonciliated cells in the oviduct/fallopian tube of pigs and women [John et al., 2002; Roldán and Marini, 2014] , in agreement with our data showing the apical staining of galectin-3 in nonciliated secretory cells of the human fallopian tube. We further demonstrated the unique localization of galectin-3 in the cilia of ciliated cells of human fallopian tube epithelium. Thus, it is reasonable to consider that the differential localization of galectin-1 and galectin-3 is established in the human fallopian tube and is related to pathophysiology of this organ, including ectopic implantation. Although the mRNA expression of galectins in the fallopian tube did not change during the menstrual phase, there seems to be a weak correlation between the expression of galectins in the fallopian tube and the serum concentration of estradiol and progesterone. As shown in figure 3 , the expression of LGALS1 tended to be positively correlated to the concentration of serum steroids, especially estradiol. On the other hand, the expression of LGALS3 seemed to be negatively correlated to that. Regulation of the expression of galectin-1 and galectin-3 by estradiol and progesterone has been reported in the murine uterus [Choe et al., 1997; Hirota et al., 2012] , human endometrial epithelial cells [Yang et al., 2012a] , and human trophoblast cell lines [Yang et al., 2011; Ramhorst et al., 2012] . Although Than et al . [2008] noted the existence of an estrogen-responsive element in the 5 ′ promoter of LGALS1, it remains unclear whether the expression of galectin-3 in the female reproductive organ is directly regulated by sex steroid hormones.
We examined, for the first time, the expression and localization of galectins in fallopian tubes from women with ectopic pregnancy. Unfortunately, it is not possible to obtain human fallopian tubes for study during a normal early pregnancy, and the effect of prolonged exposure to pregnancy hormones cannot be assessed. Thus, we had to compare the expression to the fallopian tube during the mid-secretory stage, when progesterone levels are highest, mimicking the early stages of pregnancy. There was no significant difference in the expression of LGALS1 in the fallopian tubes of women with ectopic pregnancy. Similar to that, in the nonpregnant fallopian tubes, galectin-1 protein was mainly localized to the stroma and intraepithelial leukocytes were intensely immunostained for galectin-1, while the epithelial galectin-1 immunoreaction was slightly increased in ectopic pregnancies. Although we have previously shown that immune cell populations are increased in fallopian tubes from women with ectopic pregnancy , the number of galectin-1-positive intraepithelial cells did not change between nonpregnancy and ectopic pregnancy (online suppl. fig. 1 ; see www.karger.com/doi/10.1159/439166 for all online suppl. material), suggesting that there is no significant contribution of galectin-1-positive intraepithelial cells to the development of ectopic pregnancy. In contrast, there seemed to be increased epithelial immunolabeling more generally in the fallopian tubes from women with ectopic pregnancy. As LGALS1 mRNA expression in OE-E6/E7 cells was enhanced by coculture with trophoblast SW71 cells, the increased galectin-1 immunoreaction in the fallopian tube epithelium with ectopic pregnancy may be a result of ectopic blastocyst implantation and regulated by trophoblast products. As sex steroids also can upregulate galectin-1 in the uterus [Choe et al., 1997] and LGALS1 expression tended to be positively correlated to the serum concentration of female sex steroids in the fallopian tube as revealed by this study, prolonged exposure to steroids in early pregnancy is also a potential mechanism for this change.
On the other hand, the mRNA expression of LGALS3 was significantly decreased in the fallopian tubes collected from women with ectopic pregnancy compared to those of nonpregnant women during mid-secretory phase. This may be partially due to prolonged progesterone exposure during an ectopic pregnancy. It remains possible that an altered galectin-3 expression is a cause rather than a consequence of tubal ectopic pregnancy. Downregulation of galectin-3 expression in the mouse endometrium was observed at the beginning of pregnancy [Orazizadeh et al., 2013] , suggesting that a decreased epithelial galectin-3 level is associated with successful embryo implantation. However, many researchers have noted an increased expression of galectin-3 in the uterus during pregnancy, and the numbers of implanted embryos decreased when galectin-3 was knocked down selectively in mouse endometrium [Yang et al., 2012b] . Therefore, the exact role of galectin-3 during normal blastocyst implantation and in the fallopian tube epithelium with ectopic pregnancy remains uncertain.
One interesting observation in the present study was that the subcellular localization of galectin-3 changed in the fallopian tube epithelium from women with ectopic pregnancy. Cells with galectin-3-positive cilia significantly decreased in number and there was an intimate relationship between the loss of a normal ciliary structure and the nuclear or cytoplasmic translocation of galectin-3. Koch et al. [2010] reported that galectin-3 is a novel centrosome-associated protein, and knockout of this gene resulted in the abnormal morphology of primary cilia in renal epithelial cells. Recently, the same research group demonstrated that galectin-3 at the base of the motile cilia in tracheal ciliated cells plays a crucial role in maintenance of the coordinated orientation and stabilization of motile cilia [Clare et al., 2014] . Although the function of galectin-3 in the pathogenesis of ectopic pregnancy is still unclear, translocation of galectin-3 from the cilia to the cell body could be related to ciliary loss and a decrease in ciliary motility, which is a major cause of ectopic implantation [Vasquez et al., 1983] . It remains possible that these findings are specific to fallopian tubes prone to ectopic implantation, and investigation of fallopian tubes damaged by past inflammation would be of interest.
As galectins are sugar-binding animal lectins, identification of the ligand glycoconjugates is also important to elucidate the exact role of galectins in human fallopian tubes. A previous study reported binding of biotinylated neoglycoproteins, which contain galectin-recognizing β-galactose and lactose, in the epithelium of the oviduct of rabbits [Biermann et al., 1997] . Because sialylation and fucosylation on terminal galactose of glycoconjugates are important modifications to the subtype-specific sugarbinding affinity of galectins, investigating the changes in glycan structures in the human fallopian tube would be of interest.
In conclusion, herein we describe the detailed expression of galectin-1 and galectin-3 in fallopian tubes from nonpregnant women, and their changes in fallopian tubes from women with ectopic pregnancy. The differential expression and localization of galectin-1 and galectin-3 suggest the subtype-specific contribution to the homeostasis of human fallopian tubes and to the pathogenesis of ectopic pregnancy.
